Medical device company Tandem Diabetes Care raised USD120 million in its listing. The company had put up for sale 8 million shares of common stocks priced at USD15 each share.
Domain Associates
Breaking News
aTyr Pharma reveals that it had secured up to US$59 million in financing from current investors and an anonymous global public investment fund.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- Samsung to Implement Six-Day Work Week for Executives Slammed by Critics 'Not Effective'
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Indiana Children's Museum Reportedly Exposed Total Solar Eclipse Watchers to Measles
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
